513
Views
12
CrossRef citations to date
0
Altmetric
Editorial

Modifying the NSs gene to improve live-attenuated vaccine for Rift Valley fever

&
Pages 1283-1285 | Published online: 09 Jan 2014
 

Financial & competing interests disclosure

The research to develop an improved MP-12 vaccine has been supported by the National Institute of Allergy and Infectious Diseases, NIH (R01 AI08764301 and 5 U54 AI057156) and Sealy Center for Vaccine Development at The University of Texas Medical Branch. In 2012, O Lihoradova was awarded the Maurice R Hilleman Early-Stage Career Investigator Award by the National Foundation for Infectious Diseases. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.